CALGARY, AB / ACCESS Newswire / May 29, 2025 / NXT Energy Solutions Inc. ("NXT" or the "Company") (TSX:SFD)(OTCQB:NSFDF) is pleased to announce that Ataraxia Capital ("Ataraxia"), has converted all ...

West Vancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Magnum Goldcorp Inc. (TSXV: MGI) (the "Company" or "Magnum") announces that further to its news release of May 22, 2025, the Company ...

TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in hig ...

Cancellation of 6,899,011 ordinary shares held in treasury by EQTThe cancellation was resolved by the Annual Shareholders' Meeting 2025As of 30 May 2025, there are 1,177,185,346 shares outstanding ...

NORTHAMPTON, MA / ACCESS Newswire / May 30, 2025 / Key PointsMarathon Petroleum Corporation set a company record for recognition at this year's American Fuel & Petrochemical Manufacturers safety ...

Nova Minerals Limited ("Nova" or the "Company") (NASDAQ: NVA) (ASX: NVA) (FRA: QM3)) is pleased to announce that preparations ...

MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: ...

Gross Revenue of US$19.85 Million and Cash Cost of US$874/OzVANCOUVER, British Columbia, May 30, 2025for full financial results). President and CEO Cathy Zhai commented, "In Q3 FY 2025, the flotation ...

Valvoline Global is set to make its partnership debut with FIFA's flagship tournament.The sponsorship reflects the rapid ...

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is resched ...

SAN ANTONIO, TEXAS / ACCESS Newswire / May 30, 2025 / To keep the spotlight on women in global aviation and aerospace in recent months, Olga Custodio's release of her awe-inspiring memoir, Flightpath ...

PALO ALTO, CA / ACCESS Newswire / May 30, 2025 / Riboscience, LLC, today announced the presentation of data from the completed dose escalation Phase 1a of the Phase 1a/b clinical trial of the ENPP1 in ...